|
Originally published In Press as doi:10.1074/jbc.M404170200 on May 15, 2004
J. Biol. Chem., Vol. 279, Issue 30, 31089-31097, July 23, 2004
Hepatocyte Resistance to Oxidative Stress Is Dependent on Protein Kinase C-mediated Down-regulation of c-Jun/AP-1*
Yongjun Wang ,
Jörn M. Schattenberg ,
Raina M. Rigoli ,
Peter Storz , and
Mark J. Czaja ¶
From the
Department of Medicine and Marion Bessin Liver Research Center, Albert Einstein College of Medicine, Bronx, New York 10461 and the Department of Pathology, Harvard Medical School, Boston, Massachusetts 02215
The prevention of injury from reactive oxygen species is critical for cellular resistance to many death stimuli. Resistance to death from the superoxide generator menadione in the hepatocyte cell line RALA25510G is dependent on down-regulation of the c-Jun N-terminal kinase (JNK)/AP-1 signaling pathway by extracellular signal-regulated kinase 1/2 (ERK1/2). Because protein kinase C (PKC) regulates both oxidant stress and JNK signaling, the ability of PKC to modulate hepatocyte death from menadione through effects on AP-1 was examined. PKC inhibition with Ro-31-8425 or bisindolylmaleimide I sensitized this cell line to death from menadione. Menadione treatment led to activation of PKCµ, or protein kinase D (PKD), but not PKC / , PKC / , or PKC / . Menadione induced phosphorylation of PKD at Ser-744/748, but not Ser-916, and translocation of PKD to the nucleus. PKC inhibition blocked menadione-induced phosphorylation of PKD, and expression of a constitutively active PKD prevented death from Ro-31-8425/menadione. PKC inhibition led to a sustained overactivation of JNK and c-Jun in response to menadione as determined by in vitro kinase assay and immunoblotting for the phosphorylated forms of both proteins. Cell death from PKC inhibition and menadione treatment resulted from c-Jun activation, since death was blocked by adenoviral expression of the c-Jun dominant negative TAM67. PKC and ERK1/2 independently down-regulated JNK/c-Jun, since inhibition of either kinase failed to affect activation of the other kinase, and simultaneous inhibition of both pathways caused additive JNK/c-Jun activation and cell death. Resistance to death from superoxide therefore requires both PKC/PKD and ERK1/2 activation in order to down-regulate proapoptotic JNK/c-Jun signaling.
Received for publication, April 14, 2004
, and in revised form, May 12, 2004.
* This work was supported in part by National Institutes of Health Grant DK44234 (to M. J. C.) and Deutsche Forschungsgemeinschaft Grant STO 439/1-1 (to P. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Marion Bessin Liver Research Center, Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY 10461. Tel.: 718-430-4255; Fax: 718-430-8975; E-mail: czaja{at}aecom.yu.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. A. Buder-Hoffmann, A. Shukla, T. F. Barrett, M. B. MacPherson, K. M. Lounsbury, and B. T. Mossman
A Protein Kinase C{delta}-Dependent Protein Kinase D Pathway Modulates ERK1/2 and JNK1/2 Phosphorylation and Bim-Associated Apoptosis by Asbestos
Am. J. Pathol.,
February 1, 2009;
174(2):
449 - 459.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Saberi, M. Shinohara, M. D. Ybanez, N. Hanawa, W. A. Gaarde, N. Kaplowitz, and D. Han
Regulation of H2O2-induced necrosis by PKC and AMP-activated kinase signaling in primary cultured hepatocytes
Am J Physiol Cell Physiol,
July 1, 2008;
295(1):
C50 - C63.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Chen, F. Deng, S. V. Singh, and Q. J. Wang
Protein Kinase D3 (PKD3) Contributes to Prostate Cancer Cell Growth and Survival Through a PKC{varepsilon}/PKD3 Pathway Downstream of Akt and ERK 1/2
Cancer Res.,
May 15, 2008;
68(10):
3844 - 3853.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Malhi, F. J Barreyro, H. Isomoto, S. F Bronk, and G. J Gores
Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity
Gut,
August 1, 2007;
56(8):
1124 - 1131.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kohli, X. Pan, P. Malladi, M. S. Wainwright, and P. F. Whitington
Mitochondrial Reactive Oxygen Species Signal Hepatocyte Steatosis by Regulating the Phosphatidylinositol 3-Kinase Cell Survival Pathway
J. Biol. Chem.,
July 20, 2007;
282(29):
21327 - 21336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. C Henderson, K. J Pollock, J. Frew, A. C Mackinnon, R. A Flavell, R. J Davis, T. Sethi, and K. J Simpson
Critical role of c-jun (NH2) terminal kinase in paracetamol- induced acute liver failure
Gut,
July 1, 2007;
56(7):
982 - 990.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Liu, F. Zheng, Z. Li, J. Uribarri, B. Ren, R. Hutter, J. R. Tunstead, J. Badimon, G. E. Striker, and H. Vlassara
Reduced Acute Vascular Injury and Atherosclerosis in Hyperlipidemic Mice Transgenic for Lysozyme
Am. J. Pathol.,
July 1, 2006;
169(1):
303 - 313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Song, J. Li, A. Lulla, B. M. Evers, and D. H. Chung
Protein kinase D protects against oxidative stress-induced intestinal epithelial cell injury via Rho/ROK/PKC-{delta} pathway activation
Am J Physiol Cell Physiol,
June 1, 2006;
290(6):
C1469 - C1476.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Liu, F. Zheng, Q. Cao, B. Ren, L. Zhu, G. Striker, and H. Vlassara
Amelioration of oxidant stress by the defensin lysozyme
Am J Physiol Endocrinol Metab,
May 1, 2006;
290(5):
E824 - E832.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Malhi, S. F. Bronk, N. W. Werneburg, and G. J. Gores
Free Fatty Acids Induce JNK-dependent Hepatocyte Lipoapoptosis
J. Biol. Chem.,
April 28, 2006;
281(17):
12093 - 12101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Jimenez-Lopez and A. I. Cederbaum
Protein Kinase C Signaling as a Survival Pathway against CYP2E1-Derived Oxidative Stress and Toxicity in HepG2 Cells
J. Pharmacol. Exp. Ther.,
March 1, 2005;
312(3):
998 - 1006.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|